FDA approves new treatment for difficult-to-treat metastatic melanoma
A new treatment for metastatic melanoma, a rare but fatal type of skin cancer, was authorized by the US Food and Drug Administration on Friday. Produced by Iovance Biotherapeutics, a California-based company, the medication is licensed for the treatment of patients whose skin cancer has progressed to other places of the body or cannot be…